
What Do We Know About COVID-19?: Maxillofacial Surgeons Survey
Author(s) -
Samuel Macedo Costa,
Guilherme Toledo de Lacerda,
Rayssa Nunes Villafort,
Roger Lanes Silveira,
Márcio Bruno Figueiredo Amaral
Publication year - 2020
Publication title -
the journal of craniofacial surgery/the journal of craniofacial surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.515
H-Index - 73
eISSN - 1536-3732
pISSN - 1049-2275
DOI - 10.1097/scs.0000000000006658
Subject(s) - medicine , pandemic , transmission (telecommunications) , covid-19 , myalgia , oral and maxillofacial surgery , public health , population , disease , medical emergency , intensive care medicine , emergency medicine , dentistry , environmental health , nursing , infectious disease (medical specialty) , electrical engineering , engineering
Coronavírus disease 2019 (COVID-19) is a virus of mass dissemination, with an impact on international public health, leading to hospitalizations and death. The main symptoms of COVID-19 are fever, fatigue, dry cough; however, myalgia and dyspnea and the transmission routes include direct transmission by cough, sneeze, droplet inhalation, or contact transmission with the oral, nasal, or eye mucous membranes. The dental professionals are the main risk group to COVID-19 due to the transmission routes that are directly related to the dental practice. In addition, the oral and maxillofacial surgeons (OMFS) are even more exposed, due to increased contact with the population in hospitals and emergency services. OMFS should be able to identify a suspected case of COVID-19, its symptoms, risk groups, disease severity, laboratorial and computed tomography alterations, and treatment guidelines. In the present study, the authors performed a nationwide survey with Brazilian OMFS to evaluate the knowledge of these professionals about the pandemic status of the COVID-19. A total of 142 OMFS replied the survey and the results brings light to an incomparable health public problem that the OMFS in Brazil are no able to protect itself, diagnose the suspicious and probable cases, request and interpret the correct laboratorial examinations for the treatment of the COVID-19 patients.